CCL2 and breast carcinoma: Lebrecht et al.20concluded that in patients with breast cancer, elevated MCP‐1 was associated with advanced disease; yet, Dehqanzada et al.21showed that high MCP‐1 levels were associated with favourable prognostic variables.